Published in Eur J Cardiothorac Surg on July 08, 2009
Left ventricular assist devices: a kidney's perspective. Heart Fail Rev (2015) 1.99
Continuous-flow total artificial heart supports long-term survival of a calf. Tex Heart Inst J (2009) 1.64
Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate? Curr Heart Fail Rep (2013) 1.15
Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support. Nat Rev Cardiol (2012) 1.08
Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion. J Transl Med (2011) 0.83
The first clinical case in Japan of destination therapy using the Jarvik 2000 left ventricular assist device. J Artif Organs (2010) 0.81
Physiologic and hematologic concerns of rotary blood pumps: what needs to be improved? Heart Fail Rev (2014) 0.80
Cells and pumps: Mechanical support and cellular therapy emerge as a realistic alternative to heart transplantation. Hippokratia (2012) 0.75
Jarvik 2000: evolution of surgical implantation from conventional to minimally invasive technique. Ann Cardiothorac Surg (2014) 0.75
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med (2004) 5.76
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation (2003) 3.89
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med (2015) 3.60
Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice. N Engl J Med (2015) 3.29
Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg (2007) 3.21
Conventional surgical repair and endovascular treatment of acute traumatic aortic rupture. Eur J Cardiothorac Surg (2007) 2.81
Endoscopic treatment for delayed cardiac tamponade. Eur J Cardiothorac Surg (2009) 2.68
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Iatrogenic acute aortic dissection type A: insight from the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg (2013) 2.55
Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg (2010) 2.38
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med (2005) 2.28
Assessment of aortic annulus dimensions for Edwards SAPIEN Transapical Heart Valve implantation by computed tomography: calculating average diameter using a virtual ring method. Eur J Cardiothorac Surg (2010) 2.27
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation (2008) 2.26
Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans. Ann Thorac Surg (2010) 2.21
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: what happens to the aortic root in the long run? J Thorac Cardiovasc Surg (2012) 2.17
Cardiopulmonary bypass: Evidence or experience based? J Thorac Cardiovasc Surg (2002) 2.12
Outcomes of HeartWare Ventricular Assist System support in 141 patients: a single-centre experience. Eur J Cardiothorac Surg (2012) 2.09
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med (2009) 2.08
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Effects of a comprehensive blood-sparing approach using body weight-adjusted miniaturized cardiopulmonary bypass circuits on transfusion requirements in pediatric cardiac surgery. J Thorac Cardiovasc Surg (2012) 2.06
Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J (2010) 2.06
Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg (2011) 1.94
Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg (2008) 1.94
Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg (2011) 1.93
The Tailor of Gloucester: a jacket for the Marfan's aorta. Lancet (2004) 1.91
Percutaneous aortic valve replacement: an experimental study. I. Studies on implantation. J Thorac Cardiovasc Surg (2002) 1.86
Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann Thorac Surg (2002) 1.86
Chronic critical limb ischemia. Dtsch Arztebl Int (2012) 1.86
Dislocated wrap after previous reduction aortoplasty causes erosion of the ascending aorta. Ann Thorac Surg (2003) 1.83
The STICH trial unravelled. Eur J Heart Fail (2010) 1.82
Management of patients with aortic dissection. Dtsch Arztebl Int (2008) 1.80
Perioperative management to improve neurologic outcome in thoracic or thoracoabdominal aortic stent-grafting. Ann Thorac Surg (2006) 1.76
Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation (2005) 1.74
Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial. Circulation (2004) 1.73
Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation (2008) 1.73
Endovascular aortic arch repair after aortic arch de-branching. Ann Thorac Surg (2009) 1.72
Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation (2002) 1.70
Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost (2008) 1.70
Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation (2007) 1.69
Reduction aortoplasty for dilatation of the ascending aorta in patients with bicuspid aortic valve. Ann Thorac Surg (2002) 1.67
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Fluid-dynamic modeling of the human left ventricle: methodology and application to surgical ventricular reconstruction. Ann Thorac Surg (2009) 1.66
Transapical aortic valve implantation in 194 patients: problems, complications, and solutions. Ann Thorac Surg (2010) 1.62
Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease. Interact Cardiovasc Thorac Surg (2010) 1.62
Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med (Berl) (2004) 1.62
A new miniaturized cardiopulmonary bypass system reduces transfusion requirements during neonatal cardiac surgery: initial experience in 13 consecutive patients. J Thorac Cardiovasc Surg (2008) 1.61
Aortic root abscess and secondary infective mitral valve disease: results of surgical endocarditis treatment. Eur J Cardiothorac Surg (2005) 1.59
Late wound healing problems after use of BioGlue for apical hemostasis during transapical aortic valve implantation. Interact Cardiovasc Thorac Surg (2011) 1.57
Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg (2004) 1.57
Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun (2002) 1.55
Absence of pulmonary artery growth after fontan operation and its possible impact on late outcome. Ann Thorac Surg (2009) 1.55
Orthotopic heart transplantation in patients with Marfan syndrome. Ann Thorac Surg (2007) 1.53
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg (2007) 1.53
Occlusion of the left subclavian artery with stent grafts is safer with protective reconstruction. Ann Thorac Surg (2009) 1.53
Echocardiographic strain and strain rate imaging--clinical applications. Int J Cardiol (2008) 1.53
Infectious erosion of aorta ascendens during vacuum-assisted therapy of mediastinitis. Interact Cardiovasc Thorac Surg (2010) 1.51
Preoperative assessment of aortic annulus dimensions: comparison of noninvasive and intraoperative measurement. Ann Thorac Surg (2011) 1.50
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J (2005) 1.49
Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation (2003) 1.48
The "elephant trunk" technique made easier. Ann Thorac Surg (2004) 1.47
Cardiac cell therapies: the next generation. Cardiovasc Ther (2010) 1.47
Spinal cord ischemia after thoracic stent-grafting: causes apart from intercostal artery coverage. Ann Thorac Surg (2013) 1.47
In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery. Ann Thorac Surg (2006) 1.47
Cardiac surgery for carcinoid heart disease in 12 cases. Gen Thorac Cardiovasc Surg (2011) 1.46
Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - A multicenter phase I and safety study -. Circ J (2010) 1.46
Clinical, haemodynamic and echocardiographic features of early cardiac graft dysfunction. Kardiol Pol (2012) 1.46
The everyday used nomenclature of the aortic root components: the tower of Babel? Eur J Cardiothorac Surg (2011) 1.46
Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome. Circulation (2014) 1.46
Rheumatic mitral valve repair: 22-year clinical results. J Heart Valve Dis (2011) 1.46
New insights regarding the incidence, presentation and treatment options of aorto-oesophageal fistulation after thoracic endovascular aortic repair: the European Registry of Endovascular Aortic Repair Complications. Eur J Cardiothorac Surg (2013) 1.45
Thoracic endovascular stent grafting inhibits aortic growth: an experimental study. Eur J Cardiothorac Surg (2008) 1.45
Stem cell research and cell transplantation for myocardial regeneration. Eur J Cardiothorac Surg (2005) 1.45
Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response. Ann Thorac Surg (2008) 1.45
To STICH or not to STICH: we know the answer, but do we understand the question? J Thorac Cardiovasc Surg (2005) 1.44
Mitroflow aortic pericardial bioprosthesis--clinical performance. Eur J Cardiothorac Surg (2009) 1.43
Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation. Transpl Immunol (2006) 1.42
Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med (2003) 1.42
Strain and strain rate imaging by echocardiography - basic concepts and clinical applicability. Curr Cardiol Rev (2009) 1.41
Type A aortic dissection after nonaortic cardiac surgery. Circulation (2013) 1.40
Modified Nikaidoh procedure for the correction of complex forms of transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction: mid-term results. Eur J Cardiothorac Surg (2013) 1.40
[Actual role of cardiocirculatory assistance in heart failure treatment]. G Ital Cardiol (Rome) (2010) 1.40
Solid intracardiac mass complicating peritoneovenous shunting. Interact Cardiovasc Thorac Surg (2006) 1.40
Left ventricular wall motion abnormality and myocardial dysfunction in stress cardiomyopathy: new pathophysiological aspects suggested by echocardiography. Int J Cardiol (2008) 1.40
Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. Ann Thorac Surg (2008) 1.40
Skin changes following organ transplantation: an interdisciplinary challenge. Dtsch Arztebl Int (2014) 1.39
Portable mechanical circulatory support: human experience with the LIFEBRIDGE system. Ann Thorac Surg (2011) 1.39
Built-in defect of a biological pericardial aortic prosthesis? Interact Cardiovasc Thorac Surg (2008) 1.39
Overweight is advantageous for heart-transplant candidates to survive the period of critically ill status. ASAIO J (2012) 1.39
Mitral valve repair for infective endocarditis in children. Ann Thorac Surg (2007) 1.39
An improved technique for aortic anastomosis: graft telescopic inversion. J Thorac Cardiovasc Surg (2010) 1.39
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
CO(2) embolism during minimally invasive vein harvesting. Eur J Cardiothorac Surg (2007) 1.37
Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med (2013) 1.37
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Repair of left ventricular inflow tract lesions in Shone's anomaly: valve growth and long-term outcome. Ann Thorac Surg (2012) 1.37